J&J says its psoriasis drug superior to Novartis’ in study

The study involving 1,048 participants showed Tremfya was superior to Novartis’ Cosentyx in reducing the severity and area of the body affected by the condition, which causes dry, flaky and itchy skin patches, J&J said.

Original source: https://health.economictimes.indiatimes.com/news/pharma/jj-says-its-psoriasis-drug-superior-to-novartis-in-study/67060700?utm_source=RSS&utm_medium=ETRSS

Related Posts